Page last updated: 2024-12-05

anthraquinone sulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

anthraquinone sulfonate: RN given refers to cpd with unspecified acid locant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3316477
MeSH IDM0080943

Synonyms (5)

Synonym
anthraquinone sulfonate
9,10-dioxoanthracene-1-sulfonate
30637-95-7
AE-641/00783024
9,10-dioxo-9,10-dihydro-1-anthracenesulfonate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" However, the formation of Fe(II) was not accelerated by biologically reduced AQS (B-AH2QS) because of the high bioavailability of soluble Fe(III)."( Enhanced reduction of Fe(III) oxides and methyl orange by Klebsiella oxytoca in presence of anthraquinone-2-disulfonate.
Cao, MY; Li, J; Li, WW; Tang, QW; Wang, P; Wang, S; Yu, L; Yuan, K, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (59)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (5.08)18.7374
1990's3 (5.08)18.2507
2000's17 (28.81)29.6817
2010's33 (55.93)24.3611
2020's3 (5.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]